APOA1 and psoriasis: [48] reported that this polymorphism increases the risk of psoriasis, and its presence is associated with higher circulating concentrations of malondialdehyde, apoB, lp(a) and apoB/apoAI. Further studies are required to investigate the association between specific PON-l gene polymorphisms, PON-l activity and psoriasis.